cytochrome P450 CYP2C19
Selected indexed studies
- Cytochrome P450: genotype to phenotype. (Xenobiotica, 2020) [PMID:31411087]
- Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. (J Intern Med, 2015) [PMID:25297512]
- Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants. (Biopharm Drug Dispos, 2023) [PMID:37815926]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Metabolism of sumatriptan revisited. (2023) pubmed
- Cytochrome P450: genotype to phenotype. (2020) pubmed
- Polymorphism in CYP2D6 and CYP2C19, members of the cytochrome P450 mixed-function oxidase system, in the metabolism of psychotropic drugs. (2015) pubmed
- Metabolism of testosterone and progesterone by cytochrome P450 2C19 allelic variants. (2023) pubmed
- Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase. (2019) pubmed
- Pharmacogenetics and psychopharmacotherapy. (2000) pubmed
- [Pharmacogenetics]. (2008) pubmed
- Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs. (2022) pubmed
- Impact of cytochrome P450 variation on meperidine N-demethylation to the neurotoxic metabolite normeperidine. (2020) pubmed
- Interaction of luteolin, naringenin, and their sulfate and glucuronide conjugates with human serum albumin, cytochrome P450 (CYP2C9, CYP2C19, and CYP3A4) enzymes and organic anion transporting polypeptide (OATP1B1 and OATP2B1) transporters. (2023) pubmed